Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals

Journal of Neurochemistry

Volumn 68, Issue 2, 1997, Pages 732-738

  Santiago, M ^a   Matarredona, E R ^a   Granero, L ^a   Cano, J ^a   Machado, A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

1 Methyl 4 phenylpyridinium; Dopamine; Iron chelator; Microdialysis; Rat; Striatum

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CHELATING AGENT; DEFEROXAMINE; DOPAMINE; FERRIC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; IRON CHELATION; MALE; MICRODIALYSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031012716     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68020732.x     Document Type: Article

References (48)

1. Adams J. D. and Odunze I. N. (1991) Oxygen free radicals and Parkinson's disease. Free Radic. Biol. Med. 10, 161-169.
2. +, in MPTP: A Neurologic Producing a Parkinsonian Syndrome (Markey S. P., Castagnoli N., Trevor A. J., and Kopin I. J., eds), pp. 571-574. Academic Press, New York.
3. Adams J. D., Klaidman L. K., and Odunze I. N. (1989) Oxidative effects of MPTP in the midbrain. Res. Commun. Subst. Abuse 10, 169-180.
4. Adams J. D., Odunze I. N., and Sevenian A. (1990) Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice. Biochem. Pharmacol. 39, R5-R8.
5. + induced oxygen radical formation with mitochondrial enzymes. Free Radic. Biol. Med. 15, 181-186.
6. Akenaya Y., Takahashi M., and Hatanaka H. (1995) Involvement of free-radicals in MPP neurotoxicity against rat dopaminergic-neurons in culture. Neurosci. Lett. 193, 53-56.
7. + toxicity in rat striatal slices - relationship between nonselective effects and free-radical production. Neurochem. Res. 21, 73-78.
8. Ben-Shachar D., Riederer P., and Youdim M. B. H. (1991) Iron-melanin interaction and lipid peroxidation: implication for Parkinson's disease. J. Neurochem. 57, 1609-1614.
9. Boveris A. and Chance B. (1973) The mitochondrial generation of hydrogen peroxide. Biochem. J. 134, 707-716.
10. Chacon J. N., Chedekel M. R., Land E. J., and Truscott T. G. (1987) Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 144, 957-964.
11. Chiba K., Trevor A., and Castagnoli N. Jr. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-578.
12. Chiueh C. C., Markey S. P., Burns R. S., Johannessen J. N., Pert A., and Kopin I. J. (1984) Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur. J. Pharmacol. 100, 189-194.
13. Chiueh C. C., Huang S. J., and Murphy D. L. (1992) Enhanced hydroxyl radical generation by 2′-methyl analogue of MPTP: suppression by clorgyline and deprenyl. Synapse 11, 346-348.
14. Cleeter M. W. J., Cooper J. M., and Shapira A. H. V. (1992) Irreversible inhibition of mitochodrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
15. Corsini G., Pintus S., Chiueh C. C., Weiss J. F., and Kopin I. (1985) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur. J. Pharmacol. 119, 127-128.
16. Davis C. G., Williams A. C., Markey S. P., Ebert M. H., Caine E.-D., Reichert C. M., and Kopin I. J. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249-254.
17. Desole M. S., Miele M., Esposito G., Fresu L. G., Migheli R., Zangani D., Sircana S., Grella G., and Miele E. (1995) Neuronal antioxidant system and MPTP-induced oxidative stress in the striatum and brain-stem of the rat. Pharmacol. Biochem. Behav. 51, 581-592.
18. Fee J. A. and Valentine J. S. (1977) Chemical and physical properties of superoxide, in Superoxide and Superoxide Dismutase (Michelson A. M., McCord J. M., and Fridovich I., eds), pp. 19-60. Academic Press, New York.
19. + , and analogues. Evidence against a redox cycling mechanism in MPTP neurotoxicity. Biochem. Biophys. Res. Commun. 147, 1095-1104.
20. Gerlach M., Ben-Shachar D., Riederer P., and Youdim M. B. H. (1994) Altered brain metabolism of iron as a cause of neurodegenerative disease? J. Neurochem. 63, 793-807.
21. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
22. +) induces NADH dependent superoxide formation, and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem. Biophys. Res. Commun. 170, 1049-1055.
23. Heikkila R. E., Hess A., and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224, 1451-1453.
24. +) to rats. Neurosci. Lett. 59, 135-140.
25. +) induces oxidative stress in rodent. Life Sci. 38, 743-749.
26. Langston J. W., Forno L. S., Rebert C. S., and Irwin I. (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-pheny]-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292, 390-394.
27. + on the release of serotonin and 5-hydroxyindoleacetie acid from rat striatum in vivo. Eur. J. Pharmacol. 166, 49-55.
28. Monteiro H. P. and Winterbourn C. C. (1989) 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem. Pharmacol. 38, 4177-4182.
29. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press. San Diego.
30. Perry T. L., Yong V. W., Clavier R. M., Jones K., Wright J. M., Foulks J. G., and Wall R. A. (1985) Partial protection from the dopaminergic neurotoxin MPTP by four different antioxidants in the mouse. Neurosci. Lett. 60, 109-114.
31. Riederer P. and Youdim M. B. H. (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. J. Neurochem. 46, 1359-1365.
32. +. Eur. J. Pharmacol. 126, 345-346.
33. Rollema H., De Vries J. B., Damsma G., Westerink B. H. C., Kranenborg G. L., Kuhr W. G., and Horn A. S. (1988) The use of in vivo dialysis of dopamine, acetylcholine, aminoacids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology 49, 503-511.
34. Santiago M. and Westerink B. H. C. (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn Schmiedebergs Arch. Pharmacol. 342, 407-414.
35. + on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis. Brain Res. 538, 226-230.
36. Santiago M., Westerink B. H. C., and Rollema H. (1991b) Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra. J. Neurochem. 56, 1336-1342.
37. Sershen H., Reith M. E. A., Hashim A., and Lajtha A. (1985) Protection against MPTP neurotoxicity by the antioxidant ascorbic acid. Neuropharmacology 24, 1257-1259.
38. +) reductive activation by NADPH cytochrome P-450 reductase. Biochem. Biophys. Res. Commun. 135, 583-588.
39. +) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Brain Res. 443, 101-106.
40. + administration to rat brain by in-vivo microdialysis - a model of oxidative stress. FASEB J. 9, A665.
41. Stohns S. J. and Bagchi D. (1995) Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18, 321-336.
42. Turrens J. F. and Boveris A. (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427.
43. Wegner G. C., Jarvis M. F., and Carelli R. M. (1985) Ascorbic acid reduces dopamine depletion induced by MPTP. Neuropharmacology 24, 1261-1262.
44. Westerink B. H. C., Damsma G., Rollema H., De Vries J. B., and Horn A. S. (1987) Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Life Sci. 41, 1763-1776.
45. + toxicity. Neurology 45, A380.
46. Yong V. W., Perry T. L., and Krisman A. A. (1986) Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci. Lett. 63, 56-60.
47. Youdim M. B. H., Ben-Shachar D., Eshel G., Finberg J. P. M., and Riederer P. (1993) The neurotoxicity of iron and nitric oxide: relevance to the etiology of Parkinson's disease, in Advances in Neurology, Vol. 60 (Narabayashi H., Nagatsu T., Yanagisawa N., and Mizuno Y., eds). pp. 259-266. Raven Press, New York.
48. Yu B. P. (1994) Cellular defences against damage from reactive oxygen species. Physiol. Rev. 74, 139-162.